Bosh sahifaGBM • FRA
add
Inovio Pharmaceuticals Inc
Yopilish kursi
3,80 €
Kunlik diapazon
3,85 € - 3,85 €
Yillik diapazon
3,69 € - 12,14 €
Bozor kapitalizatsiyasi
108,53 mln USD
Oʻrtacha hajm
105,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 27,35 mln | 175,54% |
Sof foyda | -25,17 mln | 25,83% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,89 | 42,95% |
EBITDA | -26,93 mln | -10,37% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 84,80 mln | -49,36% |
Jami aktivlari | 107,06 mln | -44,56% |
Jami passivlari | 33,52 mln | -38,99% |
Umumiy kapital | 73,54 mln | — |
Tarqatilgan aksiyalar | 26,10 mln | — |
Narxi/balansdagi bahosi | 1,35 | — |
Aktivlardan daromad | -56,77% | — |
Kapitaldan daromad | -69,87% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -25,17 mln | 25,83% |
Operatsiyalardan naqd pul | -27,44 mln | 5,73% |
Sarmoyadan naqd pul | 14,08 mln | 356,25% |
Moliyadan naqd pul | 660,65 ming | -5,44% |
Naqd pulning sof oʻzgarishi | -12,70 mln | 62,53% |
Boʻsh pul | -17,47 mln | 10,73% |
Haqida
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
127
